Concepedia

Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial

Nete Tofte, Morten Lindhardt, Katarina Adamova, Stephan J. L. Bakker, Joachim Beige, Joline W. J. Beulens, Andreas L. Birkenfeld, Gemma Currie, Christian Delles, Ingo Dimos,

The Lancet Diabetes & Endocrinology · 2020 · 254 citations · 25 references

DOIFull text

Open access

Concepts

References

25

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Melanie J. Davies, David A. D’Alessio, Judith Fradkin et al. · Diabetes Care · 2018 · 3.5K citations · Full text

, , +17

The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes

Hendrik Lehnert, Jens Brøchner‐Mortensen, Ramón Gomis et al. · New England Journal of Medicine · 2001 · 2.9K citations

, , +17

[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].

Hans‐Henrik Parving, Hendrik Lehnert, Jens Brøchner‐Mortensen et al. · PubMed · 2001 · 2.5K citations

, , +17

Changes in Diabetes-Related Complications in the United States, 1990–2010

Edward W. Gregg, Yanfeng Li, Jing Wang et al. · New England Journal of Medicine · 2014 · 1.7K citations · Full text

, , +15

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

Hermann Haller, Sadayoshi Ito, Joseph L. Izzo et al. · New England Journal of Medicine · 2011 · 791 citations · Full text

, , +11